• Home
  • Stock
  • Eris Lifesciences Fundamental Analysis
  • Eris Lifesciences Fundamental Analysis

Eris Lifesciences fundamental analysis

ERIS

HealthcareLarge

1590.3

3.90 (-0.24%)
Last updated on 10 Nov, 2025 | 09:17 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Eris Lifesciences Fundamentals

P/E Ratio

55.94

P/B Ratio

7.29

Div. Yield

0.46

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Eris Lifesciences Fundamentals is currently trading with a P/E Ratio of 55.94, compared to the sector average of 36.99. Its P/B Ratio stands at 7.29, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0.46%, which is than the sector’s 0.56%.

Eris Lifesciences Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Eris Lifesciences reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.